Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Lawyers Seek Leadership Roles in Xarelto Litigation January 27, 2015 Austin Kirk Add Your Comments In advance of a status conference later this week, a growing number of attorneys are filing petitions to serve in various leadership roles in the federal Xarelto litigation. Last month, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established consolidated pretrial proceedings for all product liability lawsuits filed throughout the U.S. that involve allegations that side effects of Xarelto caused users to suffer severe and often fatal bleeding injuries. The cases have been centralized as part of a federal MDL, or multidistrict litigation, before U.S. District Judge Eldon E. Fallon in the Eastern District of Louisiana to reduce duplicative discovery, avoid conflicting rulings from different judges and to serve the convenience of the parties. Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION While an initial status conference in the Xarelto MDL is set for January 29, plaintiffs’ attorneys have until February 5 to apply for various leadership roles in the litigation, including requests to serve as lead counsel or on a plaintiffs steering committee, which will take certain actions during discovery and pretrial proceedings that benefit all individuals who are pursuing a Xarelto bleeding lawsuit. More than a dozen applications have already been filed by Xarelto attorneys, including many of the same lawyers who previously served in leadership roles in the federal Pradaxa litigation, which involved similar injuries associated with another new-generation anticoagulant from the same class of medications. At the time the Xarelto MDL was established, there were at least 21 complaints pending in 10 different U.S. District Courts. However, according to the latest case list (PDF) released by the U.S. JPML on January 15, there are already at least 86 cases centralized before Judge Fallon. As Xarelto injury lawyers continue to review and file cases for individuals who experienced injuries as a result of uncontrollable bleeding problems while using the drug, it is ultimately expected that several thousand cases will be included in the MDL. Xarelto Bleeding Risks All of the cases involved in the Xarelto MDL raise similar allegations, claiming that Bayer and Johnson & Johnson’s Janssen subsidiary failed to adequately warn consumers and the medical community about the potential bleeding risks with Xarelto, as well as the lack of an effective reversal agent to allow doctors to control hemorrhaging that may develop while using the drug. Xarelto (rivaroxoaban) was the second member of a new-generation of anticoagulants introduced in recent years as a superior replacement for Coumadin (warfarin), which has been the “go-to” medication for prevention of blood clots and strokes among patients with atrial fibrillation for years. Pradaxa (dabigatran) was the first member of this class, introduced by Boehringer Ingelheim in late 2010. Shortly after the drug hit the market, it was rapidly adopted within the medical community. However, Pradaxa also quickly earned the dubious distinction as one of the medications most commonly associated with adverse event reports submitted to the FDA. Unlike warfarin, for which the blood thinning effects of the drug can be quickly reversed with a dose of vitamin K and fresh frozen plasma, no antidotes are yet available for the new-generation anticoagulants. This has left doctors unable to control or reverse bleeding problems that may occur among users. As thousands of reports began to surface involving users who suffered uncontrollable bleeding problems on Pradaxa, Boehringer Ingelheim faced over 4,000 injury lawsuits, which involve similar allegations to those now being brought in the Xarelto litigation. Shortly before the first Pradaxa trials were set to begin last year, Boehringer Ingelheim agreed to pay $650 million in Pradaxa settlements to resolve the litigation, with an average of about $150,000 to be awarded to former users who experienced injuries associated with uncontrollable bleeds. Amid the mounting concerns and lawsuits over Pradaxa bleeding problems, Xarelto was introduced in 2011, and grew to overtake the top spot among the new medications in 2013, with sales exceeding those of Pradaxa. Due to the lack of a Xarelto reversal agent, similar reports involving uncontrollable bleeding have been received among users of the drug and a growing number of product liability lawsuits have been filed throughout the federal court system. During the coordinated pretrial proceedings in the Xarelto MDL before Judge Fallon, it is ultimately expected that a small group of cases will be selected as “bellwether” claims, which will then be prepared for early trial dates. While the outcomes of these early test cases are not binding on other claims in the litigation, they are designed to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the litigation. Following coordinated pretrial proceedings and any bellwether trials, if Bayer and Johnson & Johnson’s Janssen unit fail to reach Xarelto settlements, they may face hundreds of individual trials in courts throughout the U.S. Tags: Bayer, Bleeding, Blood Thinners, Boehringer Ingelheim, Eliquis, Johnson & Johnson, Pradaxa, Xarelto More Xarelto Lawsuit Stories Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024 Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022 Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: today) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025) Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025) Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)
Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021
Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: today) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025)
Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)
Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)